Welcome to our dedicated page for Veeco Instrs Del SEC filings (Ticker: VECO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Veeco Instruments Inc. (VECO) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed manufacturer of semiconductor process equipment, Veeco reports its financial condition, material events and risk factors through documents such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
Recent Form 8-K filings illustrate the types of information investors can expect. Veeco files 8-Ks to announce quarterly financial results and to furnish related investor presentations, giving detail on net sales, operating income and other performance metrics. It also uses 8-Ks to disclose significant corporate events, including the Agreement and Plan of Merger with Axcelis Technologies, Inc., under which a wholly owned Axcelis subsidiary will merge with and into Veeco, with Veeco surviving as a wholly owned subsidiary of Axcelis, subject to specified closing conditions.
Another 8-K discusses the impact of a new U.S. Department of Commerce export control rule (the “Affiliates Rule”) on Veeco’s China-related business, indicating that, based on its preliminary review at that time, the company did not expect a material impact on its anticipated China-based business. These filings also include extensive forward-looking statements and risk factor discussions that reference Veeco’s Forms 10-K and 10-Q.
On Stock Titan, VECO filings are updated as they are made available on EDGAR. AI-powered summaries help explain the key points of complex filings, highlighting items such as merger terms, conditions to closing, governance changes, and comments on regulatory developments. Users can review historical and current filings to understand Veeco’s business description, financial reporting, and the regulatory context surrounding its planned combination with Axcelis.
Insider sale recorded: SVP Adrian Devasahayam reported a sale of 4,014 shares of Veeco Instruments Inc. common stock on 09/23/2025 at a reported price of $30 per share. After the transaction, the reporting person beneficially owned 82,120.208 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/24/2025.
Veeco Instruments (VECO) Notice of Proposed Sale (Form 144) reports an intended sale of 4,014 common shares with an aggregate market value of $120,420 to be sold on 09/23/2025 through Fidelity Brokerage Services on NASDAQ. The shares were acquired by the seller via restricted stock vesting in 2021 (2,129 on 03/17/2021; 1,202 on 05/04/2021; 683 on 06/16/2021) as compensation. The filing also discloses a recent sale on 09/15/2025 of 4,046 shares for gross proceeds of $105,196. The form includes the standard representation that the seller has no undisclosed material adverse information.
Insider sale reported: Veeco Instruments SVP Adrian Devasahayam sold 4,046 shares of Veeco common stock on 09/15/2025 at $26.00 per share, reducing his beneficial ownership to 86,134.208 shares. The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Form 144 notice for proposed sale of securities by a party associated with Veeco Instruments, Inc. The filing reports an intended sale of 4,046 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $105,196.00, to be offered on or about 09/15/2025 on the NASDAQ. The filing states 60,161,823 shares outstanding for the class. The shares were acquired by the seller via restricted stock vesting on 09/01/2021 (818 shares) and 09/14/2021 (3,228 shares) and were paid as compensation. The filing reports Nothing to Report for sales during the past three months. Several filer and issuer identification fields in the form are blank in the provided content.
Insider sale and correction: William John Miller, identified as both CEO and a director of Veeco Instruments Inc (VECO), reported a disposition of 25,000 shares of Veeco common stock at $25.00 per share, leaving him with 539,543 shares beneficially owned after the transaction. The Form 4/A amends a prior filing to correct the number of shares shown in Box 5; the amendment states no additional shares were sold beyond those disclosed in the original report. The filing also indicates the transaction was made pursuant to a written plan intended to satisfy Rule 10b5-1 affirmative defense conditions, which typically documents pre-arranged sales.
Veeco Instruments insider transaction: William John Miller, identified as the company's CEO and a director, reported a sale of 25,000 shares of Veeco Instruments Inc. (VECO) on 09/09/2025 at a price of $25 per share. After the reported sale, Mr. Miller beneficially owned 470,671 shares. The filing indicates the transaction was made pursuant to a Rule 10b5-1 trading plan. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Veeco Instruments Inc. (VECO) filed a Form 144 reporting a proposed sale of 25,000 shares of common stock through Wells Fargo Clearing Services with an aggregate market value of $624,493.00. The filing lists the approximate outstanding shares as 60,161,823 and an intended sale date of 09/09/2025 on Nasdaq.
The shares to be sold were acquired in 2024 as grants: 7,138 shares on 03/13/2024, 6,787 on 03/12/2024 and 11,075 on 03/18/2024. The filer indicates no sales in the past three months and certifies no undisclosed material adverse information. This is a routine Rule 144 notice describing a proposed sale by a person whose holdings were obtained via issuer grants.
Manulife and its investment-management subsidiaries reported beneficial ownership stakes in Veeco Instruments common stock. Manulife Investment Management (US) LLC holds 3,195,268 shares, representing 5.48% of the 58,292,152 shares outstanding cited in the filing. Manulife Investment Management Limited holds 19,763 shares (about 0.03%), and through its parent-subsidiary relationship, Manulife Financial Corporation may be deemed to beneficially own these holdings.
The Schedule 13G/A clarifies voting and dispositive powers: the reporting entities state sole voting and sole dispositive power over the shares listed. The filing is a disclosure of institutional ownership crossing the 5% threshold by MIM (US) and documents the corporate and regulatory identities of the reporting persons.